The 2009 Import and Export Market for Medicaments Containing Antibiotics or Their Derivatives in Oceana (Related Reports)

The 2009 Import and Export Market for Medicaments Containing Antibiotics or Their Derivatives in Oceana


May 16, 2009
27 Pages - SKU: ICN2315294
License type:
Online Download      US $325.00
Global Site License      US $650.00
Cuba Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
Cuba Pharmaceuticals and Healthcare Report Q2 2014 BMI View: The Cuban government continues to seek greater foreign investment to help it achieve strongeconomic growth, and is working hard to win the confidence of investors. Many companies  |  read more...
$1,295.00
Moldova Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
Moldova Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Despite the geopolitical uncertainty rising from the Russian intervention in Kiev, we believethat Moldova's healthcare and pharmaceutical market will continue to grow in 2014 as the economycontinues  |  read more...
$1,295.00
Norway Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
Norway Pharmaceuticals and Healthcare Report Q2 2014 BMI View: While Norway's reliance on pharmaceutical imports highlights opportunities for drugmakerslooking to export medicines into the country, we note that the Norwegian pharmaceutical market hasdisplayed very slow or  |  read more...
$1,295.00
Slovakia Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
Slovakia Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Slovakia generally offers significant potential as a location for pharmaceutical research. This isthanks to its demographic and epidemiological profile, which is broadly similar to Western Europe; EUmembership,  |  read more...
$1,295.00
United Kingdom Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
United Kingdom Pharmaceuticals and Healthcare Report Q2 2014 BMI View: The UK's health technology assessment and pricing/reimbursement decision making bodies arelooking to take an increasingly hard line when determining whether a new drug provides added value  |  read more...
$1,295.00
Russia Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
Russia Pharmaceuticals and Healthcare Report Q2 2014 BMI View: A deteriorating macroeconomic picture and weakening rouble will moderate realpharmaceutical industry growth, as the consumer spending that currently underpins the pharmaceuticalmarket loses momentum. Over the longer term,  |  read more...
$1,295.00
Spain Pharmaceuticals and Healthcare Report Q2 2014
3/26/2014 | published by: Business Monitor International
Spain Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Despite the Spanish economy returning to growth in 2014, the country's pharmaceuticals andhealthcare sectors show no sign of following suit. The Spanish government's ongoing cash flow troublesand  |  read more...
$1,295.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia
4/7/2014 | published by: GlobalData
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia”. It is an essential source of information on and analysis  |  read more...
$1,995.00
Physician Views: Life-cycle management strategies in multiple sclerosis – can new versions of Copaxone, Avonex drive market share retention?
3/26/2014 | published by: FirstWord
Physician Views: Life-cycle management strategies in multiple sclerosis – can new versions of Copaxone, Avonex drive market share retention? Scope With Copaxone and Avonex generating global sales  |  read more...
$645.00
Pharmaceuticals in Turkey: ISIC 2423
3/28/2014 | published by: Euromonitor International
Pharmaceuticals in Turkey: ISIC 2423 Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals market at a  |  read more...
$600.00